Noblejas-López, M.d.M.; Tébar-GarcÃa, D.; López-Rosa, R.; Alcaraz-Sanabria, A.; Cristóbal-Cueto, P.; Pinedo-Serrano, A.; Rivas-GarcÃa, L.; Galán-Moya, E.M.
TACkling Cancer by Targeting Selective Protein Degradation. Pharmaceutics 2023, 15, 2442.
https://doi.org/10.3390/pharmaceutics15102442
AMA Style
Noblejas-López MdM, Tébar-GarcÃa D, López-Rosa R, Alcaraz-Sanabria A, Cristóbal-Cueto P, Pinedo-Serrano A, Rivas-GarcÃa L, Galán-Moya EM.
TACkling Cancer by Targeting Selective Protein Degradation. Pharmaceutics. 2023; 15(10):2442.
https://doi.org/10.3390/pharmaceutics15102442
Chicago/Turabian Style
Noblejas-López, MarÃa del Mar, David Tébar-GarcÃa, Raquel López-Rosa, Ana Alcaraz-Sanabria, Pablo Cristóbal-Cueto, Alejandro Pinedo-Serrano, Lorenzo Rivas-GarcÃa, and Eva M. Galán-Moya.
2023. "TACkling Cancer by Targeting Selective Protein Degradation" Pharmaceutics 15, no. 10: 2442.
https://doi.org/10.3390/pharmaceutics15102442
APA Style
Noblejas-López, M. d. M., Tébar-GarcÃa, D., López-Rosa, R., Alcaraz-Sanabria, A., Cristóbal-Cueto, P., Pinedo-Serrano, A., Rivas-GarcÃa, L., & Galán-Moya, E. M.
(2023). TACkling Cancer by Targeting Selective Protein Degradation. Pharmaceutics, 15(10), 2442.
https://doi.org/10.3390/pharmaceutics15102442
